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Histone modifications are increasingly being used as biomarkers of cancer prognosis and survival. However, we
identified a cleavage product of histone H3 in human peripheral blood mononuclear cells, which interferes with
measures of certain H3 modifications. Therefore, the potential for enzymatic cleavage of histones should be considered
when measuring histone modifications in human samples. Furthermore, the enzymatic cleavage of human H3 is itself a
fascinating area of research and two important questions remain to be answered: 1) Does cleavage of human H3 occur
in vivo, as it does in other organisms? and 2) Does it serve a biologically important function?
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Histone modifications are increasingly being used as bio-
markers of cancer prognosis [1]. However, histones are
very sensitive to enzymatic degradation by proteases [2],
and there is evidence from many organisms that his-
tones are enzymatically cleaved in vivo; this topic is re-
ceiving increasing attention and has been reviewed
recently by several groups [3-5]. Enzymatic cleavage of
H3 has been observed in tetrahymena [6], yeast [7,8],
chicken [9], quail [10], and mouse [11,12]. Furthermore,
certain viruses can cleave host cell H3 [13,14], and
antimicrobial peptides derived from the N-terminal re-
gion of various histones (e.g., H2A, H2B, H1) have been
identified in several organisms, including fish [15-20],
molluscs [21,22], frogs [23], and even from the gastro-
intestinal tract [24] and wound fluids [25] of humans.
Until recently, there were few reports of histone cleav-
age in human cells. However, last year, Vossaert et al. re-
ported histone H3 clipping in human embryonic stem
cell (ESC) lines [26], and our group recently identified a
cleavage product of H3 in human peripheral blood
mononuclear cells (PBMCs) (Figure 1). We observe this* Correspondence: cgh2121@columbia.edu
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hibitors during histone isolation, including a protease
inhibitor cocktail (Roche), which inhibits enzymatic
cleavage of H3 in human ESCs [26], and E-64, which in-
hibits cathepsins, including Cathepsin L, which cleaves
H3 in mouse ESCs [11]. The H3 cleavage product that
we observe in human PBMCs is similar in size to the H3
cleavage product observed in mouse ESCs [11]. Extensive
cleavage of H3 is observed in approximately one-third of
these PBMC histone samples (Figure 2).
Based on Western blot, we have determined that H3
cleavage interferes with the measurement of certain
histone modifications. Figure 1A illustrates the known
enzymatic cleavage sites in H3 for mouse ESCs [19]. In
Figure 1B, Western blots illustrate total H3 (top panel)
with varying degrees of histone cleavage for 11 represen-
tative PBMC histone samples that were collected from
participants enrolled in the Folic Acid and Creatine Trial
(FACT), a randomized controlled trial of folic acid and
creatine supplementation in Bangladeshi adults [28].
Figure 1B also shows, for the same 11 PBMC samples,
three histone modifications that vary in relation to their
location on histone H3 (i.e., upstream or downstream of
the cleavage sites shown in Figure 1A). For example,
Figure 1B illustrates H3K9me2 (second panel), a modifi-
cation located downstream of known H3 cleavage sites.
Samples without large amounts of H3 cleavage (Lanes 1,entral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Enzymatic cleavage of H3 interferes with the measurement of certain histone modifications. (A) Known enzymatic cleavage sites
in H3 for mouse ESCs [11]. Bold solid lines indicate sites that are frequently cleaved, thin solid lines indicate sites that are less frequently cleaved,
and dotted lines indicate sites that are rarely cleaved [11]. (B) Western blot (Odyssey® CLx Infrared Imaging System, Li-Cor) was used to measure
total H3 protein levels (Sigma, H0164, 1:4,000) in 11 representative histone samples that had been isolated, using an acid-extraction method [27],
from PBMCs collected from arsenic-exposed Bangladeshi adults enrolled in the Folic Acid and Creatine Trial (FACT), a randomized controlled trial
of folic acid and creatine supplementation; sample collection and processing for this study has been described previously [28]. The expected size
of H3 is ~17 kDa. A distinct cleavage product of H3 is observed at ~15 kDa, and an additional H3 cleavage product between 15 and 17 kDa is
also present in several of the samples (top panel). In the same 11 samples, three histone modifications that are located in different regions of H3
were assessed by Western blot: H3K9me2 (Abcam, ab1220, 1:1,000, mouse) (second panel), H3K36me2 (Abcam, ab9049, 1:1,000, rabbit) (third panel),
and H3K79me2 (Abcam, ab3594, 1:400, rabbit) (fourth panel).
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samples with extensive cleavage of H3 (Lanes 2, 6, 7, 9)
have no detectable H3K9me2. Figure 1B also illustrates
H3K36me2 (third panel) and H3K79me2 (fourth panel),
which are histone modifications located upstream of H3
enzymatic cleavage sites; H3K36me2 is located in the tail
region of H3, and H3K79me2 is located in the core do-
main of H3 (Figure 1A). H3K36me2 and H3K79me2 canFigure 2 Extensive H3 cleavage is evident in approximately one-third
H3K36me2 and H3K79me2. Total H3 was measured in an additional 32 h
thymus (Sigma-Aldrich). H3K36me2 was also measured in 22 of the PBMC
and in ten of the PBMC samples (Samples 23–32).be detected both in the 17-kDa band of H3 that has not
been cleaved and in the <17-kDa bands of H3 that have
been cleaved (Figures 1B and 2). H3 cleavage is also de-
tectable in histones from calf thymus (Figure 2). This
has been described previously by several groups [3,29].
Similarly, cleavage of calf thymus H3 does not interfere
with upstream histone modifications, such as H3K79me2
(Figure 2). Collectively, these data suggest that H3 cleavageof PBMC histone samples, but it does not affect measures of
istone PBMC samples from the FACT study and in histones from calf
samples (Samples 1–22), and H3K79me2 was measured in calf histones
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that are situated downstream of histone cleavage sites.
Implications for molecular epidemiology studies
Since it is unclear when enzymatic cleavage of H3 occurs
in human PBMC samples, it is difficult to know if it is of
biological or methodological interest. Regardless, enzymatic
cleavage of H3 has important implications for measuring
global histone modifications in human samples. Currently,
the most commonly studied histone modifications include
methylation and acetylation marks on H3K4, H3K9, and
H3K27, which all fall within the N-terminal tail region of
H3. However, the portion of H3 that is clipped off in mouse
and human cells includes these residues. Thus, measures of
marks on H3K4, H3K9, and H3K27 may be underestimated
if samples have experienced enzymatic cleavage of H3; this
is particularly true for antibody-based methods, such as
ELISA and immunohistochemistry methods, which cannot
take into account H3 cleavage. Modifications that lie on
amino acid residues upstream of H3 enzymatic cleavage
sites, such as H3K36 and H3K79, do not appear to be af-
fected by the enzymatic cleavage of H3 and therefore can
be measured accurately, regardless of cleavage.
A better understanding of when and why enzymatic
cleavage of H3 occurs is essential. If enzymatic cleavage
of human H3 occurs in vivo, this may be an important
biological phenomenon. Alternatively, if enzymatic
cleavage occurs as a result of sample collection and pro-
cessing, preventive measures must be developed such
that all global histone modifications on H3, including
modifications on H3K4, H3K9, and H3K27, can be ac-
curately measured. In the meantime, for banked samples
previously collected for the measurement of global his-
tone marks, Western blot can be used to check samples
for enzymatic cleavage of histones. If histone cleavage
products are observed in samples, it may not be appro-
priate to measure certain histone marks based on their
location.
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